Bidirectional supply of glutamine maintains enterocyte ATP content in the in vitro using chamber model.
Glutamine is the principal energy source for enterocytes, but it is not known whether parenteral or enteral supplementation is most beneficial to gut integrity. The aim of this study was to evaluate the effects of glutamine in uni- or bidirectional supply on the viability of intestinal mucosa of starved rats during incubation in Ussing chambers. Segments of jejunum from rats starved for 48 h were randomly mounted in Ussing chambers with three nutrient solutions: Krebs buffer without glutamine; 6 mM glutamine added to the mucosal side; 6 mM glutamine added to the mucosal side and 0.6 mM glutamine to the serosal side. ATP content of the mucosa, electrophysiology, and 51Cr-ethylenediaminetetraacetate (EDTA) permeability were studied during 180 min of incubation. The addition of glutamine to both sides of the stripped mucosa improved ATP levels compared to the Krebs solution (P < 0.05), and the addition of glutamine resulted in an increase in short circuit current (P < 0.05). No significant differences were seen in 51Cr-EDTA permeability or epithelial electrical resistance. Glutamine supplementation to both the luminal and serosal side in the Ussing chamber was more effective than luminal glutamine only in maintaining ATP levels of intestinal mucosa. Bidirectional supplementation of glutamine might improve intestinal energy metabolism and viability in in vitro studies.
Yang
H
H
Department of Surgery and Clinical Research Center, Faculty of Health Science, Linköping University, 58185 Linköping, Sweden. mikael.wiren@lio.se
Söderholm
J D
JD
Larsson
J
J
Permert
J
J
Lindgren
J
J
Wirén
M
M
D000255:Adenosine Triphosphate / Q000378:metabolism*; D000818:Animals; D002614:Chelating Agents / Q000494:pharmacology; D004492:Edetic Acid / Q000494:pharmacology; D004594:Electrophysiology; D020895:Enterocytes / Q000378:metabolism*; D005508:Food Deprivation; D005973:Glutamine / Q000008:administration & dosage / Q000378:metabolism*; D007413:Intestinal Mucosa / Q000187:drug effects / Q000378:metabolism; D007552:Isotonic Solutions / Q000494:pharmacology; D007583:Jejunum / Q000187:drug effects / Q000378:metabolism; D008297:Male; D051381:Rats; D013696:Temperature; D013997:Time Factors
D002614:Chelating Agents; D007552:Isotonic Solutions; C051865:Krebs-Ringer solution; D005973:Glutamine; D000255:Adenosine Triphosphate; D004492:Edetic Acid